Published • loading... • Updated
iA appoints CFO and EVP of Research & Development to advance next phase of growth
Summary by CDR – Chain Drug Review
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
iA appoints CFO and EVP of Research & Development to advance next phase of growth
BINGHAMTON, N.Y. – iA announced the appointments of James Hammerschmidt as chief financial officer and Srinivas Chintha as executive vice president of Research & Development, further strengthening its executive leadership team as the company advances its long-term growth strategy. Hammerschmidt and Chintha bring deep experience across healthcare technology, enterprise software, and platform innovation, supporting iA’s continued focus on operatio…
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
